Glutaminases.

Adv Neurobiol

Departamento de Biología Molecular y Bioquímica, Canceromics Lab, Facultad de Ciencias, Universidad de Málaga, Málaga, 29071, Spain.

Published: September 2018

Mammalian glutaminases catalyze the stoichiometric conversion of L-glutamine to L-glutamate and ammonium ions. In brain, glutaminase is considered the prevailing pathway for synthesis of the neurotransmitter pool of glutamate. Besides neurotransmission, the products of glutaminase reaction also fulfill crucial roles in energy and metabolic homeostasis in mammalian brain. In the last years, new functional roles for brain glutaminases are being uncovered by using functional genomic and proteomic approaches. Glutaminases may act as multifunctional proteins able to perform different tasks: the discovery of multiple transcript variants in neurons and glial cells, novel extramitochondrial localizations, and isoform-specific proteininteracting partners strongly support possible moonlighting functions for these proteins. In this chapter, we present a critical account of essential works on brain glutaminase 80 years after its discovery. We will highlight the impact of recent findings and thoughts in the context of the glutamate/glutamine brain homeostasis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-45096-4_6DOI Listing

Publication Analysis

Top Keywords

brain glutaminase
8
brain
5
glutaminases
4
glutaminases mammalian
4
mammalian glutaminases
4
glutaminases catalyze
4
catalyze stoichiometric
4
stoichiometric conversion
4
conversion l-glutamine
4
l-glutamine l-glutamate
4

Similar Publications

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Background: Glutamatergic neurotransmission system dysregulation may play an important role in the pathophysiology of Alzheimer's disease (AD). However, reported results on glutamatergic components across brain regions are contradictory. Here, we conducted a systematic review with meta-analysis to examine whether there are consistent glutamatergic abnormalities in the human AD brain.

View Article and Find Full Text PDF

Background: Recent studies have reported that expanded GCA repeats in the GLS gene can cause glutaminase deficiency with ataxia phenotype. However, to data, no studies have investigated the distribution and role of GCA repeats in the GLS gene of Chinese individuals.

Objective: The aim was to investigate the distribution of GCA repeats in Chinese individuals, including undiagnosed ataxia patients for identifying causal factors, healthy controls for determining the normal range, and ATX-ATXN3 (spinocerebellar ataxia type 3, SCA3) patients for exploring genetic modifiers.

View Article and Find Full Text PDF

Ultrarare Cause of Childhood Chorea: Celiac Disease.

J Child Neurol

December 2024

Department of Pediatric Neurology, Ankara Etlik City Hospital, Ankara, Turkey.

Introduction: Chorea, a movement disorder that commonly affects children, may be caused by various diseases with metabolic, structural, pharmacologic, or autoimmune origins. Celiac disease is an autoimmune enteropathy that may rarely cause neurologic symptoms in children, primarily ataxia and peripheral neuropathy, even in the absence of gastrointestinal symptoms.

Case Report: A 9-year-old male patient diagnosed with Sydenham chorea was admitted to our clinic because of valproic acid resistance.

View Article and Find Full Text PDF
Article Synopsis
  • The stretch reflex is a key part of movement, involving muscle spindles that detect tension changes and trigger muscle contractions via nerve signals in the spinal cord.
  • Researchers have discovered a unique type of macrophage in muscle spindles that can produce and release glutamate, enhancing communication between sensory neurons and muscles.
  • Silencing these macrophages disrupts the stretch reflex and affects locomotion in mice, suggesting that they play a crucial role in sensory feedback and movement regulation, with potential implications for new treatments in movement disorders.
View Article and Find Full Text PDF

Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.

J Alzheimers Dis

November 2024

Department of Neuroscience, School of Translational Medicine, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia.

Background: Individuals with Alzheimer's disease (AD) have a heightened risk of epilepsy. However, the underlying mechanisms are not well-understood.

Objective: We aimed to elucidate the role of the glutamate-glutamine cycle in this mechanism and test the effect of ceftriaxone, a glutamate transporter-1 (GLT-1) enhancer, on seizure susceptibility in the Tg2576 mouse model of AD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!